Ra Capital Management, L.P. Wave Life Sciences Ltd. Transaction History
Ra Capital Management, L.P.
- $4.58 Billion
- Q2 2025
A detailed history of Ra Capital Management, L.P. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 18,202,009 shares of WVE stock, worth $154 Million. This represents 2.59% of its overall portfolio holdings.
Number of Shares
18,202,009
Previous 18,202,009
-0.0%
Holding current value
$154 Million
Previous $147 Million
19.55%
% of portfolio
2.59%
Previous 3.05%
Shares
6 transactions
Others Institutions Holding WVE
# of Institutions
188Shares Held
133MCall Options Held
495KPut Options Held
36.2K-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$127 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$69.8 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$56.9 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$55.2 Million0.41% of portfolio
-
M28 Capital Management LP Stamford, CT5.66MShares$47.9 Million46.96% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $734M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...